CaviWipes 2.0

The next-generation CaviWipes 2.0 builds on a decades-long reputation of being trusted by clinicians with strong efficacy claims paramount during times of public health crisis. 

Features and Benefits

  • Proven effective against SARS-CoV-2 on hard non-porous surfaces
  • Enhanced Efficacy Claims - Effective against over 60 pathogens including Norovirus and Candida auris for added confidence in preventing healthcare associated infections.
  • Excellent Material Compatibilty - Compatible with most non-porous, hard surfaces commonly used in clinical settings
  • Easy to use label - Makes it quick and easy to find critical information on efficacy, compatibility, and more
  • 2-minute universal contact time for bacteria, viruses, and pathogenic fungi (Candida auris)

Kill Claims

2-Minute Efficacy Against2

Bacteria
  • Staphylococcus aureus
  • Pseudomonas aeruginosa
  • Salmonella enterica
  • Legionella pneumophila
  • Bordetella pertussis
  • Moraxella catarrhalis
  • Enterococcus faecium
  • Klebsiella pneumoniae
  • Acinetobacter baumannii
  • Escherichia coli O157:H7
  • Micrococcus luteus
  • Streptococcus mutans
  • Burkholderia cepacia
  • Stenotrophomonas maltophilia
  • Streptococcus pyogenes
  • Chlamydophila pneumoniae
  • Flavobacterium columnare
  • Serratia marcescens
  • Klebsiella aerogenes
  • Campylobacter jejuni
  • Listeria monocytogenes
  • Shigella dysenteriae
Multi Drug-Resistant Bacteria
  • Penicillin-Resistant Streptococcus pneumoniae (PRSP)
  • Vancomycin-Resistant Enterococcus faecalis (VRE)
  • Methicillin-Resistant Staphylococcus aureus (MRSA)
  • Carbapenem-resistant Klebsiella pneumoniae (CRKP)
  • Multidrug-Resistant (Carbapenem-Resistant Acinetobacter baumannii (MRAB/ CRAB)
  • NDM-1 New Delhi metallo-beta-lactamase
  • Vancomycin-Intermediate Staphylococcus aureus (VISA)
  • Methicillin-resistant Staphylococcus epidermidis (MRSE)
  • Multi-Drug Resistant Pseudomonas aeruginosa
Mycobacterium
  • Mycobacterium tuberculosis var: bovis
Pathogenic Fungi
  • Candida albicans
  • Candida auris
Non-enveloped Viruses
  • Adenovirus Type 2
  • Human Norovirus
  • Feline calicivirus
  • Human Rotavirus
  • Enterovirus Type 71
  • Echovirus Type 11
  • Human Adenovirus Type 5
  • Rhinovirus Type 1A
Enveloped Viruses
  • Herpes simplex virus Type 1
  • Herpes simplex virus Type 2
  • lnfluenza A virus
  • lnfluenza B virus
  • Parainfluenza virus Type 3
  • Human orthopneumovirus (Respiratory Syncytial Virus)
  • SARS-associated Coronavirus
  • Measles virus
  • Hepatitis B Virus (HBV)
  • Human Hepatitis C virus (HCV)
  • Human lmmunodeficiency virus Type 1 (HlV-1)
  • Cytomegalovirus (CMV)
  • Varicella Zoster Virus (VZV)(Human Herpes Type 3)
  • Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2)

Ordering Information

CaviWipes 2.0 (6" x 6.75") - 160 Towelettes per Canister, 12 Canisters/Case

SKU 11-1410

CaviWipes 2.0 XL (9" x 12") - 65 Wipes per Canister, 12 Canisters/Case

SKU 11-1450

Wipe Wall Bracket - 12 Brackets/Case

SKU 13-1175

Resources

Click here to see all product related information and resources.

Safety Data Sheets (SDS)
CaviWipes 2.0 SDS
Safety Data Sheets (SDS)
CaviWipes 2.0 US-CAN SDS
Sales Sheet
CaviWipes 2.0 Sales Sheet
Technical Document
CaviWipes 2.0 Technical Bulletin
Safety Data Sheets (SDS)
CaviWipes 2.0 - Product Label
Sales Sheet
CaviWipes 2.0 Sales Sheet

Related Products

  • CaviCide1™

    Fast and effective one step cleaner and disinfectant available in multiple configurations to help reduce the risk of cross-contamination with a 1 minute contact time.

  • CaviWipes™ Bleach

    Demonstrates effectiveness against over 40 relevant microorganisms. 1:10 Bleach dilution. No PPE required.

  • CaviWipes™

    3 Minute cleaner and disinfectant. Made of durable non-woven towelettes that offer quick easy-to-use convenience.